A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

Clinical trial NCT06881992 · RECRUITING

Trial details

NCT number: NCT06881992
Sponsor: Rezolute
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Tumor Hyperinsulinism (Tumor HI)

Start date: 2025-04-16
Primary completion: 2027-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.